Duchenne Muscular Dystrophy Drugs Market to Grow at a CAGR
of 152.3% Over the Period 2014-2019: Radiant Insights, Inc
About Duchenne muscular dystrophy
Duchenne muscular dystrophy is an X-linked disease, which generally affects the male population. It is
characterized by progressive muscle degeneration and weakness. The disease is caused due to mutations
in the dystrophin gene, which result in the lack of production of dystrophin (a protein essential for
maintaining healthy muscle function) in individuals. The lack of dystrophin weakens muscle function,
causes loss of ambulation, harms the respiratory and cardiac function, and ultimately leads to death. The
main symptoms of this condition appears in childhood and includes delay of motor functions; progressive
muscle weakness; muscle contractures in legs; and muscle weakness in arms, neck, and more severely in
the lower half of the body. The bones also develop peculiarly, causing skeletal deformities in the patient.
Occurrences of pseudo-hypertrophy, cardiomyopathy, and breathing complications are some of the other
symptoms of this condition.
Technavio's analysts forecast the global Duchenne muscular dystrophy drugs market to grow at a CAGR
of 152.3% over the period 2014-2019.
Browse Full Report With TOC @ http://www.radiantinsights.com/research/global-duchennemuscular-dystrophy-drugs-market-2015-2019
Covered in this report
This report covers the present scenario and the growth prospects of the global Duchenne muscular
dystrophy drugs market for the period 2015-2019. To calculate the market size, the report considers
revenue generated from the sales of various off-label and branded drugs and the expected launch of drug
candidates intended to be used in the treatment of Duchenne muscular dystrophy.
Based on mechanism of action of the drugs, the market is segmented as follows:
Exon skipping mechanism
Premature stop codon red through mechanism
Others
This report includes a discussion of the market in the following three regions:
Americas: the US, Canada, Mexico, and Brazil
EMEA: the UK, Germany, Italy, France, Spain and Middle Eastern and African countries such as Israel,
South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
APAC: Japan, China, Australia, Singapore, South Korea, and India.